Secondary prophylaxis of docetaxel induced diarrhea with loperamide: case report.

J Korean Med Sci

Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.

Published: October 2013

Diarrhea is a common adverse event of docetaxel with 20%-40% of incidence and severe diarrhea occurs in 5%-6%. Several treatment guidelines for chemotherapy induced diarrhea (CID) exist, however the prophylaxis for that is not well known. We describe a new prophylactic approach for the CID with loperamide. A 72-yr-old male patient with stage IV non-small-cell lung cancer developed diarrhea repeatedly after docetaxel-cisplatin chemotherapy. His diarrhea persisted despite treatment including loperamide and fasting. However, the diarrhea was successfully prevented when loperamide was given before and after the chemotherapy. To our knowledge, this is the first report of prophylactic approach for the CID with loperamide.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792614PMC
http://dx.doi.org/10.3346/jkms.2013.28.10.1549DOI Listing

Publication Analysis

Top Keywords

induced diarrhea
8
prophylactic approach
8
approach cid
8
cid loperamide
8
diarrhea
7
loperamide
5
secondary prophylaxis
4
prophylaxis docetaxel
4
docetaxel induced
4
diarrhea loperamide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!